Clinical Trial Update: A Real-world Study of Tuberculosis Incidence in AS, PsA, or PsO Patients Treated With Secukinumab in Brazil

View source ↗

Summary

A real-world study evaluating tuberculosis incidence in patients with ankylosing spondylitis, psoriatic arthritis, or plaque psoriasis treated with secukinumab …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ankylosing Spondylitis
• Plaque Psoriasis
• Psoriatic Arthritis

Drugs mentioned

• Cosentyx (secukinumab)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Tuberculosis | Status: TERMINATED